Hexima’s Chief Science Officer, Professor Marilyn Anderson, and Onychomycosis Project Leader, Dr Michael Baker, will attend ASM Microbe 2016, held in Boston in June, to present Hexima’s antifungal technology. The conference will be an opportunity to showcase the benefits of Hexima’s technology and its progress towards clinical trials for fungal nail infections (onychomycosis).

ASM Microbe 2016 is the largest gathering of microbiologists in the world and the only meeting in the field that explores the full scope of microbiology – from basic science to translational and clinical application. By integrating ASM’s two most popular events, General Meeting and ICAAC, ASM Microbe 2016 provides unparalleled learning and networking opportunities.

Hexima-funded researchers, Dr Brigitte Hayes and PhD Student Kathy Parisi were also awarded ASM Travel Fellowships to attend the event which represents an excellent opportunity for these young researchers to present their work.

Click here to read more about ASM Microbe 2016.